Equities Analysts Offer Predictions for JAZZ Q1 Earnings
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities research analysts at Zacks Research boosted their Q1 2025 earnings per share (EPS) estimates for shares of Jazz Pharmaceuticals in a note issued to investors on Tuesday, April 29th. Zacks Research analyst S. Ganoria now expects that the specialty pharmaceutical company will earn $3.52 per share […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities research analysts at Zacks Research boosted their Q1 2025 earnings per share (EPS) estimates for shares of Jazz Pharmaceuticals in a note issued to investors on Tuesday, April 29th. Zacks Research analyst S. Ganoria now expects that the specialty pharmaceutical company will earn $3.52 per share […]
